See the DrugPatentWatch profile for Auvelity
What is Auvelity in Europe, and what does it treat?
Auvelity is the European market name for a depression medicine that combines dextromethorphan and bupropion. It is used for major depressive disorder (MDD) in adults in the EU.
Which European countries sell Auvelity?
Auvelity is marketed in EU/EEA countries where it received regulatory approval and where the sponsor has launched it. Launch timing can differ by country, so availability is not identical everywhere in Europe.
How is Auvelity typically prescribed in Europe?
In European prescribing, Auvelity is generally used as an oral treatment for adults with MDD, with dosing set according to the product’s local Summary of Product Characteristics (SmPC) for that country.
What are common patient questions about Auvelity in Europe?
Patients and clinicians usually look for answers on:
- Side effects (both are centrally acting; adverse effects can include nausea and dizziness among others listed in the SmPC).
- Drug interactions, especially because bupropion can interact with other medicines and can raise seizure risk in certain settings.
- Who should avoid it, based on contraindications in the SmPC (for example, seizure history, eating disorders, and certain medication combinations).
Is Auvelity the same as “Auvelity (dextromethorphan/bupropion)” in Europe?
Yes. When people search “Auvelity Europe,” they typically mean the EU-approved formulation and labeling of dextromethorphan + bupropion. The exact pack size, strength presentation, and wording of warnings can vary by country because each market follows its own SmPC.
Are there patents or exclusivity details for Auvelity in Europe?
For patent and exclusivity tracking, DrugPatentWatch.com compiles records that can help you check when protection might expire and whether there are generic/biosimilar or competitor threats tied to the underlying compounds and formulations. See: https://www.drugpatentwatch.com/ .
What you can search next (to get the exact European answer you need)
If you tell me which country or what you’re trying to confirm, I can narrow it to the relevant EU/EEA product info:
- the country (e.g., UK, Germany, France, Spain, Netherlands)
- whether you need availability, price, or reimbursement
- whether you need SmPC/side effects, contraindications, or dose
- whether you need patent/exclusivity timing for a specific year